CellaVision reinforces management team with a Vice President of Sales & Business Development
(Thomson Reuters ONE) -
CellaVision reinforces its management team with Ron Hagner as Vice President of
Sales & Business Development, effective from today. Mr. Hagner, based in Chapel
Hill, NC, USA, has the overall responsibility for CellaVision's global sales and
business development since 2011.
Mr. Hagner has been an employee of CellaVision since 2001, where he was
responsible for first establishing CellaVision's sales offices in the USA and
Canada, among other things.
"I'm very pleased to have Ron as part of our management team. His blend of
sales, marketing and medical laboratory knowledge has been a great asset to our
organization over the years. Ron's key responsibilities are the identification
and development of business partnerships that will aid CellaVision's future
expansion and growth, and includes management of the start-up of our market
office in China and our planned entry into the Veterinary market in North
America," says Yvonne Mårtensson, CellaVision's CEO.
Ron Hagner holds a Master's degree in Medical Biology and has more than 30
years' experience with medical device companies. Prior to CellaVision, Ron was
the Marketing Director for Bayer Diagnostics and the Vice President of Sales &
Marketing for both Intelligent Medical Imaging (Palm Beach Gardens, FL) and
Triangle Biomedical Sciences (Durham, NC).
For further information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 708 33 77 82. Email: yvonne.martensson(at)cellavision.com
About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other body
fluids in health care services. The analyses often constitute important
reference data for fast and correct diagnosis of illnesses, for example of
infections and serious cancers. CellaVision's products rationalize manual
laboratory work, and secure and support effective workflows and skills
development within and between hospitals. The company has leading-edge expertise
in image analysis, artificial intelligence and automated microscopy. In 2011
sales were SEK 155 million and sales continue to increase, with a growth target
of at least 15 % per year over an economic cycle. CellaVision's registered
office is in Lund and the company has subsidiaries in the USA, Canada and Japan.
The share is listed on the Nasdaq, OMX Stockholm, Small Cap list. Read more at
www.cellavision.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: CellaVision AB via Thomson Reuters ONE
[HUG#1606716]
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.04.2012 - 02:38 Uhr
Sprache: Deutsch
News-ID 1107953
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Lund
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 114 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CellaVision reinforces management team with a Vice President of Sales & Business Development
"
steht unter der journalistisch-redaktionellen Verantwortung von
CellaVision AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
